SA

Shun Asami

Daiichi Sankyo Co., Ltd.

Tokyo

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Associate Director, Project Management

    2023

  • Manager

    2022 - 2023

2019 - 2022

  • Senior Investment Director, Head of San Francisco

    2019 - 2022

2008 - 2019

  • Corporate Venture Investment Associate Director

    2019 - 2019

  • Corporate Strategy Department Manager

    2017 - 2019

  • Clinical Development Manager

    2008 - 2017

    I joined Eisai in 2008. My first carrier was clinical development of oncology. I had experienced several types of products including traditional anti-cancer drug and molecular targeting drugs. I specialized in oncology, working on clinical development plans, clinical trial protocols, and getting approval of new drugs in Japan.